A single dose of intravenous combretastatin A4 ‐phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers

Veterinary and Comparative Oncology, EarlyView.

Source: Veterinary and Comparative Oncology - May 25, 2018 Category: Veterinary Research Authors: E. Abma , W. De Spiegelaere , K. Vanderperren , E. Stock , L. Van Brantegem , I. Cornelis , S. Daminet , Y. Ni , M. Vynck , G. Verstraete , P. Smets , H. de Rooster Source Type: research